BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: De Ceuninck F, Gaufillier S, Bonnaud A, Sabatini M, Lesur C, Pastoureau P. YKL-40 (cartilage gp-39) induces proliferative events in cultured chondrocytes and synoviocytes and increases glycosaminoglycan synthesis in chondrocytes. Biochem Biophys Res Commun. 2001;285:926-931. [PMID: 11467840 DOI: 10.1006/bbrc.2001.5253] [Cited by in Crossref: 125] [Cited by in F6Publishing: 125] [Article Influence: 6.3] [Reference Citation Analysis]
Number Citing Articles
1 Areshkov PO, Avdieiev SS, Balynska OV, Leroith D, Kavsan VM. Two closely related human members of chitinase-like family, CHI3L1 and CHI3L2, activate ERK1/2 in 293 and U373 cells but have the different influence on cell proliferation. Int J Biol Sci 2012;8:39-48. [PMID: 22211103 DOI: 10.7150/ijbs.8.39] [Cited by in Crossref: 42] [Cited by in F6Publishing: 39] [Article Influence: 4.2] [Reference Citation Analysis]
2 Wang D, Lu JG, Wang Q, Du XL, Dong R, Wang P, Zhao L, Jiang X, Yuan LJ. Increased immunohistochemical expression of YKL-40 in the spleen of patients with portal hypertension. Braz J Med Biol Res 2012;45:264-72. [PMID: 22267006 DOI: 10.1590/s0100-879x2012007500010] [Cited by in Crossref: 9] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
3 Chen CC, Llado V, Eurich K, Tran HT, Mizoguchi E. Carbohydrate-binding motif in chitinase 3-like 1 (CHI3L1/YKL-40) specifically activates Akt signaling pathway in colonic epithelial cells. Clin Immunol. 2011;140:268-275. [PMID: 21546314 DOI: 10.1016/j.clim.2011.04.007] [Cited by in Crossref: 57] [Cited by in F6Publishing: 62] [Article Influence: 5.7] [Reference Citation Analysis]
4 Muszyński P, Groblewska M, Kulczyńska-Przybik A, Kułakowska A, Mroczko B. YKL-40 as a Potential Biomarker and a Possible Target in Therapeutic Strategies of Alzheimer's Disease. Curr Neuropharmacol 2017;15:906-17. [PMID: 28183245 DOI: 10.2174/1570159X15666170208124324] [Cited by in Crossref: 24] [Cited by in F6Publishing: 20] [Article Influence: 8.0] [Reference Citation Analysis]
5 Prakash M, Bodas M, Prakash D, Nawani N, Khetmalas M, Mandal A, Eriksson C. Diverse pathological implications of YKL-40: Answers may lie in ‘outside-in’ signaling. Cellular Signalling 2013;25:1567-73. [DOI: 10.1016/j.cellsig.2013.03.016] [Cited by in Crossref: 53] [Cited by in F6Publishing: 55] [Article Influence: 6.6] [Reference Citation Analysis]
6 Zhu H, Ji J, Lin R, Gao C, Feng L, Shen J. Surface engineering of poly(dl-lactic acid) by entrapment of alginate-amino acid derivatives for promotion of chondrogenesis. Biomaterials 2002;23:3141-8. [DOI: 10.1016/s0142-9612(02)00058-3] [Cited by in Crossref: 66] [Cited by in F6Publishing: 1] [Article Influence: 3.5] [Reference Citation Analysis]
7 Chen L, Wu W, Dentchev T, Zeng Y, Wang J, Tsui I, Tobias JW, Bennett J, Baldwin D, Dunaief JL. Light damage induced changes in mouse retinal gene expression. Exp Eye Res 2004;79:239-47. [PMID: 15325571 DOI: 10.1016/j.exer.2004.05.002] [Cited by in Crossref: 97] [Cited by in F6Publishing: 98] [Article Influence: 5.7] [Reference Citation Analysis]
8 Faibish M, Francescone R, Bentley B, Yan W, Shao R. A YKL-40-neutralizing antibody blocks tumor angiogenesis and progression: a potential therapeutic agent in cancers. Mol Cancer Ther 2011;10:742-51. [PMID: 21357475 DOI: 10.1158/1535-7163.MCT-10-0868] [Cited by in Crossref: 99] [Cited by in F6Publishing: 73] [Article Influence: 9.9] [Reference Citation Analysis]
9 Ho YY, Baron M, Recklies AD, Roughley PJ, Mort JS. Cells from the skin of patients with systemic sclerosis secrete chitinase 3-like protein 1. BBA Clin 2014;1:2-11. [PMID: 26675476 DOI: 10.1016/j.bbacli.2013.12.001] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 1.0] [Reference Citation Analysis]
10 Roslind A, Johansen JS, Junker N, Nielsen DL, Dzaferi H, Price PA, Balslev E. YKL-40 expression in benign and malignant lesions of the breast: a methodologic study. Appl Immunohistochem Mol Morphol 2007;15:371-81. [PMID: 18091378 DOI: 10.1097/01.pai.0000213146.77772.6a] [Cited by in Crossref: 14] [Cited by in F6Publishing: 15] [Article Influence: 1.1] [Reference Citation Analysis]
11 Schmidt H, Johansen JS, Gehl J, Geertsen PF, Fode K, von der Maase H. Elevated serum level of YKL-40 is an independent prognostic factor for poor survival in patients with metastatic melanoma. Cancer. 2006;106:1130-1139. [PMID: 16456816 DOI: 10.1002/cncr.21678] [Cited by in Crossref: 86] [Cited by in F6Publishing: 79] [Article Influence: 5.7] [Reference Citation Analysis]
12 Bigg HF, Wait R, Rowan AD, Cawston TE. The mammalian chitinase-like lectin, YKL-40, binds specifically to type I collagen and modulates the rate of type I collagen fibril formation. J Biol Chem 2006;281:21082-95. [PMID: 16704970 DOI: 10.1074/jbc.M601153200] [Cited by in Crossref: 99] [Cited by in F6Publishing: 38] [Article Influence: 6.6] [Reference Citation Analysis]
13 Bhardwaj R, Yester JW, Singh SK, Biswas DD, Surace MJ, Waters MR, Hauser KF, Yao Z, Boyce BF, Kordula T. RelB/p50 complexes regulate cytokine-induced YKL-40 expression. J Immunol 2015;194:2862-70. [PMID: 25681350 DOI: 10.4049/jimmunol.1400874] [Cited by in Crossref: 26] [Cited by in F6Publishing: 26] [Article Influence: 4.3] [Reference Citation Analysis]
14 Craig-Schapiro R, Perrin RJ, Roe CM, Xiong C, Carter D, Cairns NJ, Mintun MA, Peskind ER, Li G, Galasko DR, Clark CM, Quinn JF, D'Angelo G, Malone JP, Townsend RR, Morris JC, Fagan AM, Holtzman DM. YKL-40: a novel prognostic fluid biomarker for preclinical Alzheimer's disease. Biol Psychiatry 2010;68:903-12. [PMID: 21035623 DOI: 10.1016/j.biopsych.2010.08.025] [Cited by in Crossref: 240] [Cited by in F6Publishing: 242] [Article Influence: 24.0] [Reference Citation Analysis]
15 Rathcke CN, Holmkvist J, Husmoen LL, Hansen T, Pedersen O, Vestergaard H, Linneberg A. Association of polymorphisms of the CHI3L1 gene with asthma and atopy: a populations-based study of 6514 Danish adults. PLoS One 2009;4:e6106. [PMID: 19568425 DOI: 10.1371/journal.pone.0006106] [Cited by in Crossref: 35] [Cited by in F6Publishing: 37] [Article Influence: 2.9] [Reference Citation Analysis]
16 Nguyen LT, Sharma AR, Chakraborty C, Saibaba B, Ahn ME, Lee SS. Review of Prospects of Biological Fluid Biomarkers in Osteoarthritis. Int J Mol Sci 2017;18:E601. [PMID: 28287489 DOI: 10.3390/ijms18030601] [Cited by in Crossref: 57] [Cited by in F6Publishing: 50] [Article Influence: 14.3] [Reference Citation Analysis]
17 Polanski M, Anderson NL. A list of candidate cancer biomarkers for targeted proteomics. Biomark Insights. 2007;1:1-48. [PMID: 19690635 DOI: 10.1177/117727190600100001] [Cited by in Crossref: 56] [Cited by in F6Publishing: 26] [Article Influence: 4.0] [Reference Citation Analysis]
18 Nøjgaard C, Johansen JS, Christensen E, Skovgaard LT, Price PA, Becker U. Serum levels of YKL-40 and PIIINP as prognostic markers in patients with alcoholic liver disease. J Hepatol. 2003;39:179-186. [PMID: 12873813 DOI: 10.1016/s0168-8278(03)00184-3] [Cited by in Crossref: 107] [Cited by in F6Publishing: 43] [Article Influence: 6.3] [Reference Citation Analysis]
19 Zhu CB, Chen LL, Tian JJ, Su L, Wang C, Gai ZT, Du WJ, Ma GL. Elevated serum YKL-40 level predicts poor prognosis in hepatocellular carcinoma after surgery. Ann Surg Oncol. 2012;19:817-825. [PMID: 21861215 DOI: 10.1245/s10434-011-2026-3] [Cited by in Crossref: 22] [Cited by in F6Publishing: 25] [Article Influence: 2.2] [Reference Citation Analysis]
20 Koch BE, Stougaard J, Spaink HP. Keeping track of the growing number of biological functions of chitin and its interaction partners in biomedical research. Glycobiology 2015;25:469-82. [PMID: 25595947 DOI: 10.1093/glycob/cwv005] [Cited by in Crossref: 40] [Cited by in F6Publishing: 34] [Article Influence: 6.7] [Reference Citation Analysis]
21 Böckelmann LC, Felix T, Calabrò S, Schumacher U. YKL-40 protein expression in human tumor samples and human tumor cell line xenografts: implications for its use in tumor models. Cell Oncol (Dordr) 2021;44:1183-95. [PMID: 34432260 DOI: 10.1007/s13402-021-00630-z] [Reference Citation Analysis]
22 Kros JM, Mustafa DM, Dekker LJ, Sillevis Smitt PA, Luider TM, Zheng PP. Circulating glioma biomarkers. Neuro Oncol 2015;17:343-60. [PMID: 25253418 DOI: 10.1093/neuonc/nou207] [Cited by in Crossref: 25] [Cited by in F6Publishing: 46] [Article Influence: 3.6] [Reference Citation Analysis]
23 Mistrangelo M, Senetta R, Racca P, Castellano I, Chiusa L, Bellò M, Ricardi U, Morino M, Cassoni P. A novel biomarker-based analysis reliably predicts nodal metastases in anal carcinoma: preliminary evidence of therapeutic impact. Colorectal Dis 2013;15:1382-91. [PMID: 23692332 DOI: 10.1111/codi.12289] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 0.6] [Reference Citation Analysis]
24 Francescone RA, Scully S, Faibish M, Taylor SL, Oh D, Moral L, Yan W, Bentley B, Shao R. Role of YKL-40 in the angiogenesis, radioresistance, and progression of glioblastoma. J Biol Chem. 2011;286:15332-15343. [PMID: 21385870 DOI: 10.1074/jbc.m110.212514] [Cited by in Crossref: 142] [Cited by in F6Publishing: 94] [Article Influence: 14.2] [Reference Citation Analysis]
25 Johansen JS, Schultz NA, Jensen BV. Plasma YKL-40: a potential new cancer biomarker? Future Oncol 2009;5:1065-82. [PMID: 19792974 DOI: 10.2217/fon.09.66] [Cited by in Crossref: 96] [Cited by in F6Publishing: 106] [Article Influence: 8.0] [Reference Citation Analysis]
26 Deutschmann C, Roggenbuck D, Schierack P. The loss of tolerance to CHI3L1 – A putative role in inflammatory bowel disease? Clinical Immunology 2019;199:12-7. [DOI: 10.1016/j.clim.2018.12.005] [Cited by in Crossref: 5] [Cited by in F6Publishing: 4] [Article Influence: 2.5] [Reference Citation Analysis]
27 Rousseau A, Nutt CL, Betensky RA, Iafrate AJ, Han M, Ligon KL, Rowitch DH, Louis DN. Expression of oligodendroglial and astrocytic lineage markers in diffuse gliomas: use of YKL-40, ApoE, ASCL1, and NKX2-2. J Neuropathol Exp Neurol 2006;65:1149-56. [PMID: 17146289 DOI: 10.1097/01.jnen.0000248543.90304.2b] [Cited by in Crossref: 55] [Cited by in F6Publishing: 50] [Article Influence: 3.9] [Reference Citation Analysis]
28 Rath T, Roderfeld M, Güler C, Wenzel C, Graf J, Beitinger F, Roeb E, Zachoval R. YKL-40 and transient elastography, a powerful team to assess hepatic fibrosis. Scandinavian Journal of Gastroenterology 2011;46:1369-80. [DOI: 10.3109/00365521.2011.613949] [Cited by in Crossref: 19] [Cited by in F6Publishing: 19] [Article Influence: 1.9] [Reference Citation Analysis]
29 Østergaard C, Johansen JS, Benfield T, Price PA, Lundgren JD. YKL-40 is elevated in cerebrospinal fluid from patients with purulent meningitis. Clin Diagn Lab Immunol 2002;9:598-604. [PMID: 11986266 DOI: 10.1128/cdli.9.3.598-604.2002] [Cited by in Crossref: 10] [Cited by in F6Publishing: 35] [Article Influence: 0.5] [Reference Citation Analysis]
30 De Ceuninck F, Berenbaum F. Proteomics: addressing the challenges of osteoarthritis. Drug Discovery Today 2009;14:661-7. [DOI: 10.1016/j.drudis.2009.05.006] [Cited by in Crossref: 13] [Cited by in F6Publishing: 12] [Article Influence: 1.1] [Reference Citation Analysis]
31 Johansen JS, Christensen IJ, Riisbro R, Greenall M, Han C, Price PA, Smith K, Brünner N, Harris AL. High serum YKL-40 levels in patients with primary breast cancer is related to short recurrence free survival. Breast Cancer Res Treat 2003;80:15-21. [PMID: 12889595 DOI: 10.1023/A:1024431000710] [Cited by in Crossref: 88] [Cited by in F6Publishing: 47] [Article Influence: 4.9] [Reference Citation Analysis]
32 Gözükara İ, Özgür T, Dolapçıoğlu K, Güngören A, Karapınar OS. YKL-40 expression in abnormal invasive placenta cases. J Perinat Med 2017;45:571-5. [PMID: 27977409 DOI: 10.1515/jpm-2016-0208] [Reference Citation Analysis]
33 Mylin AK, Rasmussen T, Johansen JS, Knudsen LM, Nørgaard PH, Lenhoff S, Dahl IM, Johnsen HE. Serum YKL-40 concentrations in newly diagnosed multiple myeloma patients and YKL-40 expression in malignant plasma cells. Eur J Haematol. 2006;77:416-424. [PMID: 16930142 DOI: 10.1111/j.0902-4441.2006.t01-1-ejh2879.x] [Cited by in Crossref: 24] [Cited by in F6Publishing: 6] [Article Influence: 1.6] [Reference Citation Analysis]
34 Zhao T, Su Z, Li Y, Zhang X, You Q. Chitinase-3 Like-protein-1 function and its role in diseases. Signal Transduct Target Ther. 2020;5:201. [PMID: 32929074 DOI: 10.1038/s41392-020-00303-7] [Cited by in Crossref: 14] [Cited by in F6Publishing: 15] [Article Influence: 14.0] [Reference Citation Analysis]
35 Hao H, Chen H, Xie L, Liu H, Wang D. LncRNA KCNQ1OT1 Promotes Proliferation, Invasion and Metastasis of Prostate Cancer by Regulating miR-211-5p/CHI3L1 Pathway. Onco Targets Ther 2021;14:1659-71. [PMID: 33688211 DOI: 10.2147/OTT.S288785] [Cited by in Crossref: 2] [Article Influence: 2.0] [Reference Citation Analysis]
36 Carboni RCS, Behrens Pinto GL, Shinjo SK. High YKL-40 serum levels and its expression in the muscle tissues of patients with antisynthetase syndrome. Adv Rheumatol 2021;61:44. [PMID: 34225813 DOI: 10.1186/s42358-021-00199-z] [Reference Citation Analysis]
37 Kacira T, Hanimoglu H, Kucur M, Sanus GZ, Kafadar AM, Tanriverdi T, Kaynar MY. Elevated cerebrospinal fluid and serum YKL-40 levels are not associated with symptomatic vasospasm in patients with aneurysmal subarachnoid haemorrhage. J Clin Neurosci 2008;15:1011-6. [PMID: 18280741 DOI: 10.1016/j.jocn.2006.11.014] [Cited by in Crossref: 8] [Cited by in F6Publishing: 6] [Article Influence: 0.6] [Reference Citation Analysis]
38 Shackel NA, McGuinness PH, Abbott CA, Gorrell MD, McCaughan GW. Novel differential gene expression in human cirrhosis detected by suppression subtractive hybridization. Hepatology. 2003;38:577-588. [PMID: 12939584 DOI: 10.1053/jhep.2003.50376] [Cited by in Crossref: 38] [Cited by in F6Publishing: 36] [Article Influence: 2.1] [Reference Citation Analysis]
39 Huang Q, Xie X, Liang G, Gong F, Wang Y, Wei X, Wang Q, Ji Z, Chen Q. The GH18 family of chitinases: Their domain architectures, functions and evolutions. Glycobiology 2012;22:23-34. [DOI: 10.1093/glycob/cwr092] [Cited by in Crossref: 48] [Cited by in F6Publishing: 39] [Article Influence: 4.8] [Reference Citation Analysis]
40 Liton PB, Liu X, Stamer WD, Challa P, Epstein DL, Gonzalez P. Specific targeting of gene expression to a subset of human trabecular meshwork cells using the chitinase 3-like 1 promoter. Invest Ophthalmol Vis Sci 2005;46:183-90. [PMID: 15623772 DOI: 10.1167/iovs.04-0330] [Cited by in Crossref: 36] [Cited by in F6Publishing: 35] [Article Influence: 2.3] [Reference Citation Analysis]
41 Seibold MA, Donnelly S, Solon M, Innes A, Woodruff PG, Boot RG, Burchard EG, Fahy JV. Chitotriosidase is the primary active chitinase in the human lung and is modulated by genotype and smoking habit. J Allergy Clin Immunol 2008;122:944-950.e3. [PMID: 18845328 DOI: 10.1016/j.jaci.2008.08.023] [Cited by in Crossref: 69] [Cited by in F6Publishing: 71] [Article Influence: 5.3] [Reference Citation Analysis]
42 Zhu H, Ji J, Lin R, Gao C, Feng L, Shen J. Surface engineering of poly(D,L-lactic acid) by entrapment of chitosan-based derivatives for the promotion of chondrogenesis. J Biomed Mater Res 2002;62:532-9. [PMID: 12221701 DOI: 10.1002/jbm.10313] [Cited by in Crossref: 59] [Cited by in F6Publishing: 50] [Article Influence: 3.3] [Reference Citation Analysis]
43 Andreassen M, Vestergaard H, Kristensen LØ. Concentrations of the acute phase reactants high-sensitive C-reactive protein and YKL-40 and of interleukin-6 before and after treatment in patients with acromegaly and growth hormone deficiency. Clinical Endocrinology 2007;67:909-16. [DOI: 10.1111/j.1365-2265.2007.02986.x] [Cited by in Crossref: 16] [Cited by in F6Publishing: 16] [Article Influence: 1.1] [Reference Citation Analysis]
44 Davis A, Mackay C. Osteoarthritis year in review: outcome of rehabilitation. Osteoarthritis and Cartilage 2013;21:1414-24. [DOI: 10.1016/j.joca.2013.08.013] [Cited by in Crossref: 22] [Cited by in F6Publishing: 22] [Article Influence: 2.8] [Reference Citation Analysis]
45 Houston DR, Recklies AD, Krupa JC, van Aalten DM. Structure and Ligand-induced Conformational Change of the 39-kDa Glycoprotein from Human Articular Chondrocytes. Journal of Biological Chemistry 2003;278:30206-12. [DOI: 10.1074/jbc.m303371200] [Cited by in Crossref: 104] [Cited by in F6Publishing: 38] [Article Influence: 5.8] [Reference Citation Analysis]
46 Bossé Y, Miqdad A, Fournier D, Pépin A, Pibarot P, Mathieu P. Refining molecular pathways leading to calcific aortic valve stenosis by studying gene expression profile of normal and calcified stenotic human aortic valves. Circ Cardiovasc Genet 2009;2:489-98. [PMID: 20031625 DOI: 10.1161/CIRCGENETICS.108.820795] [Cited by in Crossref: 85] [Cited by in F6Publishing: 53] [Article Influence: 7.1] [Reference Citation Analysis]
47 Recklies AD, Ling H, White C, Bernier SM. Inflammatory Cytokines Induce Production of CHI3L1 by Articular Chondrocytes. Journal of Biological Chemistry 2005;280:41213-21. [DOI: 10.1074/jbc.m510146200] [Cited by in Crossref: 118] [Cited by in F6Publishing: 57] [Article Influence: 7.4] [Reference Citation Analysis]
48 Itik V, Kemik O, Kemik A, Dulger AC, Sümer A, Soyoral YU, Begenik H, Purisa S, Kotan C. Serum YKL-40 Levels in Patients with Gastric Cancer. Biomark Cancer 2011;3:25-30. [PMID: 24179388 DOI: 10.4137/BIC.S7154] [Cited by in Crossref: 6] [Cited by in F6Publishing: 4] [Article Influence: 0.6] [Reference Citation Analysis]
49 Kaynar MY, Tanriverdi T, Kafadar AM, Kacira T, Yurdakul F, Uzun H, Gumustas K. YKL-40 levels in the cerebrospinal fluid and serum of patients with aneurysmal subarachnoid hemorrhage: preliminary results. J Clin Neurosci 2005;12:754-7. [PMID: 16153848 DOI: 10.1016/j.jocn.2005.06.001] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 0.5] [Reference Citation Analysis]
50 Johansen JS, Pedersen AN, Schroll M, Jørgensen T, Pedersen BK, Bruunsgaard H. High serum YKL-40 level in a cohort of octogenarians is associated with increased risk of all-cause mortality. Clin Exp Immunol 2008;151:260-6. [PMID: 18070151 DOI: 10.1111/j.1365-2249.2007.03561.x] [Cited by in Crossref: 32] [Cited by in F6Publishing: 37] [Article Influence: 2.3] [Reference Citation Analysis]
51 Shao R. YKL-40 acts as an angiogenic factor to promote tumor angiogenesis. Front Physiol 2013;4:122. [PMID: 23755018 DOI: 10.3389/fphys.2013.00122] [Cited by in Crossref: 57] [Cited by in F6Publishing: 59] [Article Influence: 7.1] [Reference Citation Analysis]
52 Aigner T, Bartnik E, Zien A, Zimmer R. Functional genomics of osteoarthritis. Pharmacogenomics 2002;3:635-50. [DOI: 10.1517/14622416.3.5.635] [Cited by in Crossref: 18] [Cited by in F6Publishing: 15] [Article Influence: 0.9] [Reference Citation Analysis]
53 Fikry EM, Gad AM, Eid AH, Arab HH. Caffeic acid and ellagic acid ameliorate adjuvant-induced arthritis in rats via targeting inflammatory signals, chitinase-3-like protein-1 and angiogenesis. Biomedicine & Pharmacotherapy 2019;110:878-86. [DOI: 10.1016/j.biopha.2018.12.041] [Cited by in Crossref: 26] [Cited by in F6Publishing: 24] [Article Influence: 13.0] [Reference Citation Analysis]
54 Park SJ, Jun YJ, Kim TH, Jung JY, Hwang GH, Jung KJ, Lee SH, Lee HM, Lee SH. Increased expression of YKL-40 in mild and moderate/severe persistent allergic rhinitis and its possible contribution to remodeling of nasal mucosa. Am J Rhinol Allergy 2013;27:372-80. [PMID: 24119600 DOI: 10.2500/ajra.2013.27.3941] [Cited by in Crossref: 21] [Cited by in F6Publishing: 21] [Article Influence: 3.0] [Reference Citation Analysis]
55 Roslind A, Johansen JS. YKL-40: a novel marker shared by chronic inflammation and oncogenic transformation. Methods Mol Biol 2009;511:159-84. [PMID: 19347297 DOI: 10.1007/978-1-59745-447-6_7] [Cited by in Crossref: 33] [Cited by in F6Publishing: 34] [Article Influence: 2.8] [Reference Citation Analysis]
56 Martel-Pelletier J, Boileau C, Pelletier JP, Roughley PJ. Cartilage in normal and osteoarthritis conditions. Best Pract Res Clin Rheumatol. 2008;22:351-384. [PMID: 18455690 DOI: 10.1016/j.berh.2008.02.001] [Cited by in Crossref: 298] [Cited by in F6Publishing: 266] [Article Influence: 22.9] [Reference Citation Analysis]
57 Fukushima N, Koopmann J, Sato N, Prasad N, Carvalho R, Leach SD, Hruban RH, Goggins M. Gene expression alterations in the non-neoplastic parenchyma adjacent to infiltrating pancreatic ductal adenocarcinoma. Mod Pathol. 2005;18:779-787. [PMID: 15791284 DOI: 10.1038/modpathol.3800337] [Cited by in Crossref: 57] [Cited by in F6Publishing: 48] [Article Influence: 3.6] [Reference Citation Analysis]
58 Kjaergaard AD, Johansen JS, Bojesen SE, Nordestgaard BG. Role of inflammatory marker YKL-40 in the diagnosis, prognosis and cause of cardiovascular and liver diseases. Crit Rev Clin Lab Sci 2016;53:396-408. [PMID: 27187575 DOI: 10.1080/10408363.2016.1190683] [Cited by in Crossref: 23] [Cited by in F6Publishing: 23] [Article Influence: 4.6] [Reference Citation Analysis]
59 Nielsen AR, Plomgaard P, Krabbe KS, Johansen JS, Pedersen BK. IL-6, but not TNF-α, increases plasma YKL-40 in human subjects. Cytokine. 2011;55:152-155. [PMID: 21478032 DOI: 10.1016/j.cyto.2011.03.014] [Cited by in Crossref: 60] [Cited by in F6Publishing: 58] [Article Influence: 6.0] [Reference Citation Analysis]
60 Junker N, Johansen JS, Andersen CB, Kristjansen PE. Expression of YKL-40 by peritumoral macrophages in human small cell lung cancer. Lung Cancer. 2005;48:223-231. [PMID: 15829322 DOI: 10.1016/j.lungcan.2004.11.011] [Cited by in Crossref: 81] [Cited by in F6Publishing: 76] [Article Influence: 5.1] [Reference Citation Analysis]
61 Mylin AK, Abildgaard N, Johansen JS, Andersen NF, Heickendorff L, Standal T, Gimsing P, Knudsen LM. High serum YKL-40 concentration is associated with severe bone disease in newly diagnosed multiple myeloma patients. Eur J Haematol 2008;80:310-7. [DOI: 10.1111/j.1600-0609.2007.01027.x] [Cited by in Crossref: 13] [Cited by in F6Publishing: 14] [Article Influence: 1.0] [Reference Citation Analysis]
62 Ling H, Recklies AD. The chitinase 3-like protein human cartilage glycoprotein 39 inhibits cellular responses to the inflammatory cytokines interleukin-1 and tumour necrosis factor-alpha. Biochem J. 2004;380:651-659. [PMID: 15015934 DOI: 10.1042/bj20040099] [Cited by in Crossref: 172] [Cited by in F6Publishing: 150] [Article Influence: 10.1] [Reference Citation Analysis]
63 Shao R, Cao QJ, Arenas RB, Bigelow C, Bentley B, Yan W. Breast cancer expression of YKL-40 correlates with tumour grade, poor differentiation, and other cancer markers. Br J Cancer. 2011;105:1203-1209. [PMID: 21934681 DOI: 10.1038/bjc.2011.347] [Cited by in Crossref: 37] [Cited by in F6Publishing: 37] [Article Influence: 3.7] [Reference Citation Analysis]
64 Omar MA, Ao Y, Li M, He K, Xu L, Tong H, Jiang M, Li F. The functional difference of eight chitinase genes between male and female of the cotton mealybug, Phenacoccus solenopsis: Chitinase genes between sexes of cotton mealybugs. Insect Mol Biol 2019;28:550-67. [DOI: 10.1111/imb.12572] [Cited by in Crossref: 17] [Cited by in F6Publishing: 11] [Article Influence: 8.5] [Reference Citation Analysis]
65 Yamada K, Hattori E, Iwayama Y, Toyota T, Ohnishi T, Iwata Y, Tsuchiya KJ, Sugihara G, Kikuchi M, Okazaki Y, Yoshikawa T. Failure to confirm genetic association of the CHI3L1 gene with schizophrenia in Japanese and Chinese populations. Am J Med Genet 2009;150B:508-14. [DOI: 10.1002/ajmg.b.30847] [Cited by in Crossref: 3] [Cited by in F6Publishing: 5] [Article Influence: 0.3] [Reference Citation Analysis]
66 Lin YS, Liu YF, Chou YE, Yang SF, Chien MH, Wu CH, Chou CH, Cheng CW, Wang PH. Correlation of chitinase 3-like 1 single nucleotide polymorphisms and haplotypes with uterine cervical cancer in Taiwanese women. PLoS One 2014;9:e104038. [PMID: 25203433 DOI: 10.1371/journal.pone.0104038] [Cited by in Crossref: 9] [Cited by in F6Publishing: 10] [Article Influence: 1.3] [Reference Citation Analysis]
67 Recklies AD, White C, Ling H. The chitinase 3-like protein human cartilage glycoprotein 39 (HC-gp39) stimulates proliferation of human connective-tissue cells and activates both extracellular signal-regulated kinase- and protein kinase B-mediated signalling pathways. Biochem J. 2002;365:119-126. [PMID: 12071845 DOI: 10.1042/bj20020075] [Cited by in Crossref: 264] [Cited by in F6Publishing: 243] [Article Influence: 13.9] [Reference Citation Analysis]
68 Bhat KP, Pelloski CE, Zhang Y, Kim SH, deLaCruz C, Rehli M, Aldape KD. Selective repression of YKL-40 by NF-kappaB in glioma cell lines involves recruitment of histone deacetylase-1 and -2. FEBS Lett 2008;582:3193-200. [PMID: 18708058 DOI: 10.1016/j.febslet.2008.08.010] [Cited by in Crossref: 35] [Cited by in F6Publishing: 35] [Article Influence: 2.7] [Reference Citation Analysis]
69 Erzin Y, Uzun H, Karatas A, Celik AF. Serum YKL-40 as a marker of disease activity and stricture formation in patients with Crohn’s disease. J Gastroenterol Hepatol. 2008;23:e357-e362. [PMID: 17725598 DOI: 10.1111/j.1440-1746.2007.05121.x] [Cited by in Crossref: 37] [Cited by in F6Publishing: 35] [Article Influence: 2.6] [Reference Citation Analysis]
70 Johansen JS, Jensen BV, Roslind A, Price PA. Is YKL-40 a new therapeutic target in cancer? Expert Opinion on Therapeutic Targets 2007;11:219-34. [DOI: 10.1517/14728222.11.2.219] [Cited by in Crossref: 38] [Cited by in F6Publishing: 39] [Article Influence: 2.7] [Reference Citation Analysis]
71 Ruhl T, Stromps JP, Depenau LM, Kim BS, Pallua N. Concentration of Chondrogenic Soluble Factors in Freshly Harvested Lipoaspirate. Ann Plast Surg 2019;83:344-51. [PMID: 30994491 DOI: 10.1097/SAP.0000000000001936] [Reference Citation Analysis]
72 Bernardi D, Podswiadek M, Zaninotto M, Punzi L, Plebani M. YKL-40 as a marker of joint involvement in inflammatory bowel disease. Clin Chem. 2003;49:1685-1688. [PMID: 14500601 DOI: 10.1373/49.10.1685] [Cited by in Crossref: 20] [Cited by in F6Publishing: 22] [Article Influence: 1.1] [Reference Citation Analysis]
73 Cintin C, Johansen JS, Christensen IJ, Price PA, Sørensen S, Nielsen HJ. High serum YKL-40 level after surgery for colorectal carcinoma is related to short survival. Cancer. 2002;95:267-274. [PMID: 12124825 DOI: 10.1002/cncr.10644] [Cited by in Crossref: 91] [Cited by in F6Publishing: 82] [Article Influence: 4.8] [Reference Citation Analysis]
74 Park JA, Drazen JM, Tschumperlin DJ. The chitinase-like protein YKL-40 is secreted by airway epithelial cells at base line and in response to compressive mechanical stress. J Biol Chem 2010;285:29817-25. [PMID: 20650887 DOI: 10.1074/jbc.M110.103416] [Cited by in Crossref: 56] [Cited by in F6Publishing: 34] [Article Influence: 5.1] [Reference Citation Analysis]
75 El-asrar MA, Elbarbary NS, Ismail EAR, Elshenity AM. Serum YKL-40 in young patients with β-thalassemia major: Relation to hepatitis C virus infection, liver stiffness by transient elastography and cardiovascular complications. Blood Cells, Molecules, and Diseases 2016;56:1-8. [DOI: 10.1016/j.bcmd.2015.09.006] [Cited by in Crossref: 8] [Cited by in F6Publishing: 6] [Article Influence: 1.6] [Reference Citation Analysis]
76 Johansen JS, Milman N, Hansen M, Garbarsch C, Price PA, Graudal N. Increased serum YKL-40 in patients with pulmonary sarcoidosis--a potential marker of disease activity? Respir Med. 2005;99:396-402. [PMID: 15763444 DOI: 10.1016/j.rmed.2004.09.016] [Cited by in Crossref: 65] [Cited by in F6Publishing: 67] [Article Influence: 3.8] [Reference Citation Analysis]
77 Sutherland TE. Chitinase-like proteins as regulators of innate immunity and tissue repair: helpful lessons for asthma? Biochem Soc Trans 2018;46:141-51. [PMID: 29351964 DOI: 10.1042/BST20170108] [Cited by in Crossref: 17] [Cited by in F6Publishing: 8] [Article Influence: 5.7] [Reference Citation Analysis]
78 Sutherland TE, Maizels RM, Allen JE. Chitinases and chitinase-like proteins: potential therapeutic targets for the treatment of T-helper type 2 allergies. Clin Exp Allergy. 2009;39:943-955. [PMID: 19400900 DOI: 10.1111/j.1365-2222.2009.03243.x] [Cited by in Crossref: 61] [Cited by in F6Publishing: 62] [Article Influence: 5.1] [Reference Citation Analysis]
79 Thongsom S, Chaocharoen W, Silsirivanit A, Wongkham S, Sripa B, Choe H, Suginta W, Talabnin C. YKL-40/chitinase-3-like protein 1 is associated with poor prognosis and promotes cell growth and migration of cholangiocarcinoma. Tumour Biol. 2016;37:9451-9463. [PMID: 26781979 DOI: 10.1007/s13277-016-4838-z] [Cited by in Crossref: 19] [Cited by in F6Publishing: 19] [Article Influence: 3.8] [Reference Citation Analysis]
80 Mitsuhashi A, Matsui H, Usui H, Nagai Y, Tate S, Unno Y, Hirashiki K, Seki K, Shozu M. Serum YKL-40 as a marker for cervical adenocarcinoma. Ann Oncol. 2009;20:71-77. [PMID: 18723551 DOI: 10.1093/annonc/mdn552] [Cited by in Crossref: 36] [Cited by in F6Publishing: 37] [Article Influence: 2.8] [Reference Citation Analysis]
81 Schultz NA, Johansen JS. YKL-40-A Protein in the Field of Translational Medicine: A Role as a Biomarker in Cancer Patients? Cancers (Basel) 2010;2:1453-91. [PMID: 24281168 DOI: 10.3390/cancers2031453] [Cited by in Crossref: 39] [Cited by in F6Publishing: 37] [Article Influence: 3.5] [Reference Citation Analysis]
82 Nordenbaek C, Johansen JS, Halberg P, Wiik A, Garbarsch C, Ullman S, Price PA, Jacobsen S. High serum levels of YKL-40 in patients with systemic sclerosis are associated with pulmonary involvement. Scand J Rheumatol. 2005;34:293-297. [PMID: 16195162 DOI: 10.1080/03009740510018598] [Cited by in Crossref: 57] [Cited by in F6Publishing: 52] [Article Influence: 3.6] [Reference Citation Analysis]
83 Li TM, Liu SC, Huang YH, Huang CC, Hsu CJ, Tsai CH, Wang SW, Tang CH. YKL-40-Induced Inhibition of miR-590-3p Promotes Interleukin-18 Expression and Angiogenesis of Endothelial Progenitor Cells. Int J Mol Sci 2017;18:E920. [PMID: 28448439 DOI: 10.3390/ijms18050920] [Cited by in Crossref: 22] [Cited by in F6Publishing: 20] [Article Influence: 5.5] [Reference Citation Analysis]
84 Musumeci M, Caruso V, Medulla E, Torrisi V, Migale R, Angeletti S, Musumeci S. Serum YKL-40 levels and chitotriosidase activity in patients with beta-thalassemia major. Dis Markers 2014;2014:965971. [PMID: 24808626 DOI: 10.1155/2014/965971] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.3] [Reference Citation Analysis]
85 Elhai M, Avouac J, Allanore Y. Circulating lung biomarkers in idiopathic lung fibrosis and interstitial lung diseases associated with connective tissue diseases: Where do we stand? Semin Arthritis Rheum 2020;50:480-91. [PMID: 32089354 DOI: 10.1016/j.semarthrit.2020.01.006] [Cited by in Crossref: 12] [Cited by in F6Publishing: 12] [Article Influence: 12.0] [Reference Citation Analysis]
86 Deutschmann C, Sowa M, Murugaiyan J, Roesler U, Röber N, Conrad K, Laass MW, Bogdanos D, Sipeki N, Papp M, Rödiger S, Roggenbuck D, Schierack P. Identification of Chitinase-3-Like Protein 1 as a Novel Neutrophil Antigenic Target in Crohn's Disease. J Crohns Colitis 2019;13:894-904. [PMID: 30753386 DOI: 10.1093/ecco-jcc/jjz012] [Cited by in Crossref: 8] [Cited by in F6Publishing: 7] [Article Influence: 8.0] [Reference Citation Analysis]
87 Tschirdewahn S, Reis H, Niedworok C, Nyirady P, Szendröi A, Schmid KW, Shariat SF, Kramer G, vom Dorp F, Rübben H, Szarvas T. Prognostic effect of serum and tissue YKL-40 levels in bladder cancer. Urologic Oncology: Seminars and Original Investigations 2014;32:663-9. [DOI: 10.1016/j.urolonc.2014.02.004] [Cited by in Crossref: 12] [Cited by in F6Publishing: 13] [Article Influence: 1.7] [Reference Citation Analysis]
88 Pizano-Martínez O, Yañez-Sánchez I, Alatorre-Carranza P, Miranda-Díaz A, Ortiz-Lazareno PC, García-Iglesias T, Daneri-Navarro A, Mercado MVD, Fafutis-Morris M, Delgado-Rizo V. YKL-40 expression in CD14+ liver cells in acute and chronic injury. World J Gastroenterol 2011; 17(33): 3830-3835 [PMID: 21987626 DOI: 10.3748/wjg.v17.i33.3830] [Cited by in CrossRef: 12] [Cited by in F6Publishing: 15] [Article Influence: 1.2] [Reference Citation Analysis]
89 Ringsholt M, Høgdall EV, Johansen JS, Price PA, Christensen LH. YKL-40 protein expression in normal adult human tissues--an immunohistochemical study. J Mol Histol 2007;38:33-43. [PMID: 17242979 DOI: 10.1007/s10735-006-9075-0] [Cited by in Crossref: 46] [Cited by in F6Publishing: 48] [Article Influence: 3.3] [Reference Citation Analysis]
90 Libreros S, Garcia-Areas R, Iragavarapu-Charyulu V. CHI3L1 plays a role in cancer through enhanced production of pro-inflammatory/pro-tumorigenic and angiogenic factors. Immunol Res. 2013;57:99-105. [PMID: 24222276 DOI: 10.1007/s12026-013-8459-y] [Cited by in Crossref: 56] [Cited by in F6Publishing: 59] [Article Influence: 8.0] [Reference Citation Analysis]
91 Kim SH, Das K, Noreen S, Coffman F, Hameed M. Prognostic implications of immunohistochemically detected YKL-40 expression in breast cancer. World J Surg Oncol 2007;5:17. [PMID: 17286869 DOI: 10.1186/1477-7819-5-17] [Cited by in Crossref: 26] [Cited by in F6Publishing: 27] [Article Influence: 1.9] [Reference Citation Analysis]
92 Jiang L, Wang Y, Peng Q, Shu X, Wang G, Wu X. Serum YKL-40 level is associated with severity of interstitial lung disease and poor prognosis in dermatomyositis with anti-MDA5 antibody. Clin Rheumatol 2019;38:1655-63. [DOI: 10.1007/s10067-019-04457-w] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 2.5] [Reference Citation Analysis]
93 Huang K, Wu LD. YKL-40: a potential biomarker for osteoarthritis. J Int Med Res 2009;37:18-24. [PMID: 19215669 DOI: 10.1177/147323000903700102] [Cited by in Crossref: 38] [Cited by in F6Publishing: 35] [Article Influence: 3.2] [Reference Citation Analysis]
94 Yan L, Deng Y, Zhou J, Zhao H, Wang G; China HepB-Related Fibrosis Assessment Research Group. Serum YKL-40 as a biomarker for liver fibrosis in chronic hepatitis B patients with normal and mildly elevated ALT. Infection 2018;46:385-93. [PMID: 29600444 DOI: 10.1007/s15010-018-1136-2] [Cited by in Crossref: 17] [Cited by in F6Publishing: 15] [Article Influence: 5.7] [Reference Citation Analysis]
95 Salamon J, Hoffmann T, Elies E, Peldschus K, Johansen JS, Lüers G, Schumacher U, Wicklein D. Antibody directed against human YKL-40 increases tumor volume in a human melanoma xenograft model in scid mice. PLoS One 2014;9:e95822. [PMID: 24752554 DOI: 10.1371/journal.pone.0095822] [Cited by in Crossref: 12] [Cited by in F6Publishing: 12] [Article Influence: 1.7] [Reference Citation Analysis]
96 Singh SK, Bhardwaj R, Wilczynska KM, Dumur CI, Kordula T. A complex of nuclear factor I-X3 and STAT3 regulates astrocyte and glioma migration through the secreted glycoprotein YKL-40. J Biol Chem 2011;286:39893-903. [PMID: 21953450 DOI: 10.1074/jbc.M111.257451] [Cited by in Crossref: 45] [Cited by in F6Publishing: 34] [Article Influence: 4.5] [Reference Citation Analysis]
97 Furukawa T, Matsui K, Kitano M, Yokoyama Y, Sekiguchi M, Azuma N, Imai Y, Hirota S, Yamanishi K, Sano H. Relationship between YKL-40 and pulmonary arterial hypertension in systemic sclerosis. Modern Rheumatology 2019;29:476-83. [DOI: 10.1080/14397595.2018.1480256] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 1.3] [Reference Citation Analysis]
98 Anand V, Jaswal S, Singh S, Kumar S, Jena MK, Verma AK, Yadav ML, Janjanam J, Lotfan M, Malakar D, Dang AK, Mohanty TK, Kaushik JK, Mohanty AK. Functional characterization of Mammary Gland Protein-40, a chitinase-like glycoprotein expressed during mammary gland apoptosis. Apoptosis 2016;21:209-24. [DOI: 10.1007/s10495-015-1196-z] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 1.0] [Reference Citation Analysis]
99 Hozumi H, Fujisawa T, Enomoto N, Nakashima R, Enomoto Y, Suzuki Y, Kono M, Karayama M, Furuhashi K, Murakami A, Inui N, Nakamura Y, Mimori T, Suda T. Clinical Utility of YKL-40 in Polymyositis/dermatomyositis-associated Interstitial Lung Disease. J Rheumatol 2017;44:1394-401. [DOI: 10.3899/jrheum.170373] [Cited by in Crossref: 18] [Cited by in F6Publishing: 17] [Article Influence: 4.5] [Reference Citation Analysis]
100 Inamoto Y, Martin PJ, Onstad LE, Cheng GS, Williams KM, Pusic I, Ho VT, Arora M, Pidala J, Flowers MED, Gooley TA, Lawler RL, Hansen JA, Lee SJ. Relevance of Plasma Matrix Metalloproteinase-9 for Bronchiolitis Obliterans Syndrome after Allogeneic Hematopoietic Cell Transplantation. Transplant Cell Ther 2021;27:759.e1-8. [PMID: 34126278 DOI: 10.1016/j.jtct.2021.06.006] [Reference Citation Analysis]
101 Kido J, Bando Y, Bando M, Kajiura Y, Hiroshima Y, Inagaki Y, Murata H, Ikuta T, Kido R, Naruishi K, Funaki M, Nagata T. YKL-40 level in gingival crevicular fluid from patients with periodontitis and type 2 diabetes. Oral Dis. 2015;21:667-673. [PMID: 25740558 DOI: 10.1111/odi.12334] [Cited by in Crossref: 7] [Cited by in F6Publishing: 9] [Article Influence: 1.2] [Reference Citation Analysis]
102 Pinet S, Bessette B, Vedrenne N, Lacroix A, Richard L, Jauberteau MO, Battu S, Lalloué F. TrkB-containing exosomes promote the transfer of glioblastoma aggressiveness to YKL-40-inactivated glioblastoma cells. Oncotarget 2016;7:50349-64. [PMID: 27385098 DOI: 10.18632/oncotarget.10387] [Cited by in Crossref: 42] [Cited by in F6Publishing: 42] [Article Influence: 14.0] [Reference Citation Analysis]
103 Lai T, Wu D, Chen M, Cao C, Jing Z, Huang L, Lv Y, Zhao X, Lv Q, Wang Y, Li D, Wu B, Shen H. YKL-40 expression in chronic obstructive pulmonary disease: relation to acute exacerbations and airway remodeling. Respir Res 2016;17:31. [PMID: 27013031 DOI: 10.1186/s12931-016-0338-3] [Cited by in Crossref: 15] [Cited by in F6Publishing: 23] [Article Influence: 3.0] [Reference Citation Analysis]
104 Chen CC, Pekow J, Llado V, Kanneganti M, Lau CW, Mizoguchi A, Mino-Kenudson M, Bissonnette M, Mizoguchi E. Chitinase 3-like-1 expression in colonic epithelial cells as a potentially novel marker for colitis-associated neoplasia. Am J Pathol. 2011;179:1494-1503. [PMID: 21763261 DOI: 10.1016/j.ajpath.2011.05.038] [Cited by in Crossref: 42] [Cited by in F6Publishing: 46] [Article Influence: 4.2] [Reference Citation Analysis]
105 Jacques C, Recklies AD, Levy A, Berenbaum F. HC-gp39 contributes to chondrocyte differentiation by inducing SOX9 and type II collagen expressions. Osteoarthritis Cartilage 2007;15:138-46. [PMID: 16949314 DOI: 10.1016/j.joca.2006.07.003] [Cited by in Crossref: 30] [Cited by in F6Publishing: 26] [Article Influence: 2.0] [Reference Citation Analysis]
106 Einarsson JM, Bahrke S, Sigurdsson BT, Ng CH, Petersen PH, Sigurjonsson OE, Jonsson H Jr, Gislason J, Thormodsson FR, Peter MG. Partially acetylated chitooligosaccharides bind to YKL-40 and stimulate growth of human osteoarthritic chondrocytes. Biochem Biophys Res Commun 2013;434:298-304. [PMID: 23541584 DOI: 10.1016/j.bbrc.2013.02.122] [Cited by in Crossref: 12] [Cited by in F6Publishing: 13] [Article Influence: 1.5] [Reference Citation Analysis]
107 Petersson M, Bucht E, Granberg B, Stark A. Effects of arginine-vasopressin and parathyroid hormone-related protein (1–34) on cell proliferation and production of YKL-40 in cultured chondrocytes from patients with rheumatoid arthritis and osteoarthritis. Osteoarthritis and Cartilage 2006;14:652-9. [DOI: 10.1016/j.joca.2006.01.003] [Cited by in Crossref: 12] [Cited by in F6Publishing: 11] [Article Influence: 0.8] [Reference Citation Analysis]
108 Rathcke CN, Vestergaard H. YKL-40--an emerging biomarker in cardiovascular disease and diabetes. Cardiovasc Diabetol. 2009;8:61. [PMID: 19930630 DOI: 10.1186/1475-2840-8-61] [Cited by in Crossref: 115] [Cited by in F6Publishing: 115] [Article Influence: 9.6] [Reference Citation Analysis]
109 Dehn H, Høgdall EVS, Johansen JS, Jørgensen M, Price PA, Engelholm SAA, Høgdall CK. Plasma YKL-40, as a prognostic tumor marker in recurrent ovarian cancer: YKL-40 and ovarian cancer. Acta Obstetricia et Gynecologica Scandinavica 2003;82:287-93. [DOI: 10.1034/j.1600-0412.2003.00010.x] [Cited by in Crossref: 63] [Cited by in F6Publishing: 56] [Article Influence: 3.5] [Reference Citation Analysis]
110 Eurich K, Segawa M, Toei-Shimizu S, Mizoguchi E. Potential role of chitinase 3-like-1 in inflammation-associated carcinogenic changes of epithelial cells. World J Gastroenterol 2009; 15(42): 5249-5259 [PMID: 19908331 DOI: 10.3748/wjg.15.5249] [Cited by in CrossRef: 55] [Cited by in F6Publishing: 56] [Article Influence: 4.6] [Reference Citation Analysis]
111 Scully S, Yan W, Bentley B, Cao QJ, Shao R. Inhibitory activity of YKL-40 in mammary epithelial cell differentiation and polarization induced by lactogenic hormones: a role in mammary tissue involution. PLoS One 2011;6:e25819. [PMID: 21991364 DOI: 10.1371/journal.pone.0025819] [Cited by in Crossref: 22] [Cited by in F6Publishing: 24] [Article Influence: 2.2] [Reference Citation Analysis]
112 Yamac D, Ozturk B, Coskun U, Tekin E, Sancak B, Yildiz R, Atalay C. Serum YKL-40 levels as a prognostic factor in patients with locally advanced breast cancer. Adv Ther 2008;25:801-9. [PMID: 18670741 DOI: 10.1007/s12325-008-0082-2] [Cited by in Crossref: 23] [Cited by in F6Publishing: 23] [Article Influence: 1.9] [Reference Citation Analysis]
113 Komi DE, Kazemi T, Bussink AP. New Insights Into the Relationship Between Chitinase-3-Like-1 and Asthma. Curr Allergy Asthma Rep 2016;16:57. [PMID: 27438466 DOI: 10.1007/s11882-016-0637-2] [Cited by in Crossref: 16] [Cited by in F6Publishing: 16] [Article Influence: 4.0] [Reference Citation Analysis]
114 Badariotti F, Kypriotou M, Lelong C, Dubos MP, Renard E, Galera P, Favrel P. The phylogenetically conserved molluscan chitinase-like protein 1 (Cg-Clp1), homologue of human HC-gp39, stimulates proliferation and regulates synthesis of extracellular matrix components of mammalian chondrocytes. J Biol Chem 2006;281:29583-96. [PMID: 16882657 DOI: 10.1074/jbc.M605687200] [Cited by in Crossref: 47] [Cited by in F6Publishing: 19] [Article Influence: 3.1] [Reference Citation Analysis]
115 Junker N, Johansen JS, Hansen LT, Lund EL, Kristjansen PE. Regulation of YKL-40 expression during genotoxic or microenvironmental stress in human glioblastoma cells. Cancer Science 2005;96:183-90. [DOI: 10.1111/j.1349-7006.2005.00026.x] [Cited by in Crossref: 88] [Cited by in F6Publishing: 83] [Article Influence: 5.5] [Reference Citation Analysis]
116 Johansen JS, Høyer PE, Larsen LA, Price PA, Møllgård K. YKL-40 protein expression in the early developing human musculoskeletal system. J Histochem Cytochem 2007;55:1213-28. [PMID: 17712177 DOI: 10.1369/jhc.7A7245.2007] [Cited by in Crossref: 67] [Cited by in F6Publishing: 29] [Article Influence: 4.8] [Reference Citation Analysis]
117 Polacek M, Bruun JA, Johansen O, Martinez I. Comparative Analyses of the Secretome from Dedifferentiated and Redifferentiated Adult Articular Chondrocytes. Cartilage 2011;2:186-96. [PMID: 26069579 DOI: 10.1177/1947603510383856] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 0.8] [Reference Citation Analysis]
118 Furuhashi K, Suda T, Nakamura Y, Inui N, Hashimoto D, Miwa S, Hayakawa H, Kusagaya H, Nakano Y, Nakamura H, Chida K. Increased expression of YKL-40, a chitinase-like protein, in serum and lung of patients with idiopathic pulmonary fibrosis. Respir Med 2010;104:1204-10. [PMID: 20347285 DOI: 10.1016/j.rmed.2010.02.026] [Cited by in Crossref: 80] [Cited by in F6Publishing: 77] [Article Influence: 7.3] [Reference Citation Analysis]
119 Coffman FD. Chitinase 3-Like-1 (CHI3L1): a putative disease marker at the interface of proteomics and glycomics. Crit Rev Clin Lab Sci. 2008;45:531-562. [PMID: 19003601 DOI: 10.1080/10408360802334743] [Cited by in Crossref: 77] [Cited by in F6Publishing: 80] [Article Influence: 6.4] [Reference Citation Analysis]
120 Bi J, Lau SH, Lv ZL, Xie D, Li W, Lai YR, Zhong JM, Wu HQ, Su Q, He YL. Overexpression of YKL-40 is an independent prognostic marker in gastric cancer. Hum Pathol. 2009;40:1790-1797. [PMID: 19765801 DOI: 10.1016/j.humpath.2009.07.005] [Cited by in Crossref: 37] [Cited by in F6Publishing: 34] [Article Influence: 3.1] [Reference Citation Analysis]
121 Lavery K, Hawley S, Swain P, Rooney R, Falb D, Alaoui-ismaili MH. New insights into BMP-7 mediated osteoblastic differentiation of primary human mesenchymal stem cells. Bone 2009;45:27-41. [DOI: 10.1016/j.bone.2009.03.656] [Cited by in Crossref: 50] [Cited by in F6Publishing: 51] [Article Influence: 4.2] [Reference Citation Analysis]
122 Yu G, Ji J, Shen J. Synthesis and characterization of cholesterol-poly(ethylene glycol)-poly(D,L-lactic acid) copolymers for promoting osteoblast attachment and proliferation. J Mater Sci: Mater Med 2006;17:899-909. [DOI: 10.1007/s10856-006-0188-5] [Cited by in Crossref: 6] [Cited by in F6Publishing: 4] [Article Influence: 0.4] [Reference Citation Analysis]
123 Andreassen M, Raymond I, Hildebrandt P, Kistorp C, Rathcke C, Vestergaard H, Faber J, Kristensen LØ. Associations between plasma insulin-like growth factor-I and the markers of inflammation interleukin 6, C-reactive protein and YKL-40 in an elderly background population. Inflamm Res 2010;59:503-10. [DOI: 10.1007/s00011-009-0154-z] [Cited by in Crossref: 9] [Cited by in F6Publishing: 9] [Article Influence: 0.8] [Reference Citation Analysis]
124 Zhang Q, Li J, Xie H, Xue H, Wang Y. A network-based pathway-expanding approach for pathway analysis. BMC Bioinformatics 2016;17:536. [PMID: 28155638 DOI: 10.1186/s12859-016-1333-x] [Cited by in Crossref: 3] [Cited by in F6Publishing: 4] [Article Influence: 0.6] [Reference Citation Analysis]
125 Keles ZP, Keles GC, Avci B, Cetinkaya BO, Emingil G. Analysis of YKL-40 Acute-Phase Protein and Interleukin-6 Levels in Periodontal Disease. Journal of Periodontology 2014;85:1240-6. [DOI: 10.1902/jop.2014.130631] [Cited by in Crossref: 19] [Cited by in F6Publishing: 23] [Article Influence: 2.7] [Reference Citation Analysis]